Drug discovery database

A new database of information on the properties and activities of drugs and drug-like small molecules and their targets, launched in January 2010 with data on more than 520,000 compounds. The database is now hosted by the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) having been transferred from biotech firm Galapagos NV in July 2008 through a GBP4.7 million (about $7.6m) Strategic Award from the Wellcome Trust. ChEMBLdb is unique in focusing on drug discovery and because of its size; 520,000 small molecules and 2.4 million records of their effects on biological systems.